Company Overview of CGI Pharmaceuticals, Inc.
CGI Pharmaceuticals, Inc., a development-stage pharmaceutical company, discovers and develops small molecule therapeutics for multiple oncology and immunology-based indications. The company provides drug discovery and development programs, including Btk, a B-cell kinase for a range of AAID and oncology indications; and Syk, a regulator of mast cell, monocyte/macrophage, and B-cell functions. CGI Pharmaceuticals, Inc. was formerly known as Cellular Genomics, Inc. and changed its name in September, 2005. The company was founded in 1998 and is headquartered in Branford, Connecticut. As of July 8, 2010, CGI Pharmaceuticals, Inc. operates as a subsidiary of Gilead Sciences Inc.
36 East Industrial Road
Branford, CT 06405
Founded in 1998
Key Executives for CGI Pharmaceuticals, Inc.
Similar Private Companies By Industry
|Biodtech, Inc.||United States|
|JRX Biotechnology, Inc.||United States|
|Human Genome Sciences Inc.||United States|
|Bomac Vets-Plus, Inc.||United States|
|Imstem Biotechnology, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Post a JobJobs
- Fredericksburg, VA | AstellasPosted: Mar 07
- Princeton, NJ | RGPPosted: Mar 05
- Philadelphia, PA | PwCPosted: Apr 09
- Missouri | AstellasPosted: Feb 21
Sponsored Financial Commentaries
To contact CGI Pharmaceuticals, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.